Sunshine Biopharma (SBFM) Operating Income (2011 - 2026)
Sunshine Biopharma's (SBFM) quarterly Operating Income came in at -$1.4 million in Q1 2026, down 7.71% YoY from -$1.5 million in Q1 2025, and up 22.03% on a QoQ basis from -$1.8 million in Q4 2025.
Sunshine Biopharma (SBFM) Operating Income (2011 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 15 years of Operating Income data on file, last reported at -$1.4 million in Q1 2026.
- Quarterly Operating Income fell 7.71% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.3 million (down 10.84% YoY) and the FY2025 annual result came in at -$6.2 million, down 7.14% from the prior year.
- Operating Income grew to -$1.4 million in Q1 2026, from -$1.8 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$695796.0 in Q2 2022 to a low of -$23.4 million in Q4 2022.
- A 5-year average of -$2.7 million and a median of -$1.3 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income tumbled 8255.16% — and 2023, when it soared 94.92%.
- Tracing SBFM's Operating Income over 5 years: stood at -$23.4 million in 2022, then soared by 94.92% to -$1.2 million in 2023, then plunged by 71.64% to -$2.0 million in 2024, then grew by 12.16% to -$1.8 million in 2025, then rose by 22.03% to -$1.4 million in 2026.
- The last three Operating Income figures came in at -$1.4 million (Q1 2026), -$1.8 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sunshine Biopharma | 1.53 Mn | -12.22 Mn | 2.43 Mn | -1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.61 Mn |
| Mar 31, 2026 | -1.40 Mn |
| Dec 31, 2025 | -1.79 Mn |
| Sep 30, 2025 | -1.09 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Mar 31, 2025 | -1.30 Mn |
| Dec 31, 2024 | -2.04 Mn |
| Sep 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Mar 31, 2024 | -1.35 Mn |
| Dec 31, 2023 | -1.19 Mn |
| Sep 30, 2023 | -779,474.00 |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -1.83 Mn |
| Dec 31, 2022 | -23.36 Mn |
| Sep 30, 2022 | -1.72 Mn |
| Jun 30, 2022 | -695,796.00 |
| Mar 31, 2022 | -1.22 Mn |
| Dec 31, 2021 | -279,631.00 |
| Sep 30, 2021 | -496,259.00 |